Boardroom Alpha
Boardroom Alpha
NXL · Current Report (Form 8-K) · Filed June 17, 2026

Nexalin Technology Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 17, 2026
Period
Jun 16, 2026
Ticker
NXL
Accession
0001829126-26-006624
Boardroom Alpha · Filing insights

Nexalin Technology adopted the Second Amended and Restated Bylaws effective immediately, updating nominations, consent rights, quorum, and forum provisions.

About Nexalin Technology Inc
Market cap
$7M
1Y TSR
−60.7%
3Y TSR
−16.5%
Board grade
D
Sector
Healthcare
CEO
Mark White
Last annual meeting: Aug 11, 2026 · View full Nexalin Technology Inc profile →

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 16, 2026

 

NEXALIN TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41507   27-5566468
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1776 Yorktown, Suite 550, Houston, Texas

   77056
(Address of principal executive offices)  

(Zip Code)

 

Registrant’s telephone number, including area code: (832) 260-0222

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of each exchange on which registered
Common Stock, par value $0.001 per share   NXL   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

   

 

 

Item 5.03.Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On June 16, 2026, the Board of Directors (the “Board”) of Nexalin Technology, Inc. (the “Company”) adopted the Company’s Second Amended and Restated Bylaws (as so amended and restated, the “Second Amended and Restated Bylaws”), which became effective immediately upon adoption. The Second Amended and Restated Bylaws amend and restate the Company’s Amended and Restated Bylaws, as previously in effect (the “Prior Bylaws”).

 

The Second Amended and Restated Bylaws include, among other things, amendments that revise the advance notice procedures for stockholder director nominations and other stockholder business, including to address Rule 14a-19 under the Securities Exchange Act of 1934, as amended, timing requirements and limits on the number of stockholder nominees; and modify the procedures for stockholder nominations at special meetings, including to address Rule 14a-19 and to clarify that such procedures are the exclusive means for stockholder nominations at special meetings.

 

The Second Amended and Restated Bylaws also revise provisions regarding notices and waivers of notice for stockholder meetings, voting standards for stockholder action, adjournments, recesses and postponements of stockholder meetings, and the list of stockholders entitled to vote at stockholder meetings. In addition, the Second Amended and Restated Bylaws lower the quorum standard for stockholder meetings from a majority of the voting power of outstanding shares to one-third of the voting power of outstanding shares. The Second Amended and Restated Bylaws further replace the Prior Bylaws’ prohibition on stockholder action by written consent or electronic transmission with procedures for stockholder action by consent without a meeting, including procedures relating to record dates, requests to fix record dates and review of consents and revocations by independent inspectors of election.

 

In addition, the Second Amended and Restated Bylaws revise provisions relating to the Board, including provisions addressing the single-class Board structure, director terms, vacancies, future-effective resignations, director removal, Board meeting procedures and the organization of Board meetings. The Second Amended and Restated Bylaws also update provisions regarding the Company’s officers, stock certificates and uncertificated shares, lost certificates, transfers of stock and record dates.

 

The Second Amended and Restated Bylaws further amend and restate the indemnification and advancement provisions applicable to directors and executive officers, update the notice provisions to conform to Section 232 of the Delaware General Corporation Law, revise the amendment provision to clarify the Board’s authority to adopt, amend or repeal the Second Amended and Restated Bylaws unless otherwise provided by the Company’s certificate of incorporation, and make various other technical, conforming, clarifying and administrative changes.

 

The Second Amended and Restated Bylaws also add a forum selection provision providing that, unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if such court does not have subject matter jurisdiction, the federal district court of the State of Delaware) will be the exclusive forum for certain internal corporate claims, including derivative actions, claims for breach of fiduciary duty, claims arising under the Delaware General Corporation Law, the Company’s certificate of incorporation or bylaws, and claims governed by the internal affairs doctrine, and that the federal district courts of the United States will be the exclusive forum for claims arising under the Securities Act of 1933, as amended; provided that the forum selection provision does not apply to claims arising under the Securities Exchange Act of 1934, as amended.

 

The foregoing summary of the amendments effected by the Second Amended and Restated Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Second Amended and Restated Bylaws, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

1

 

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
3.1   Second Amended and Restated Bylaws of Nexalin Technology, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 17, 2026 NEXALIN TECHNOLOGY, INC.
   
  /s/ Mark White
  Mark White
  Chief Executive Officer

 

3

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Nexalin Technology Inc (NXL)

Reference

Frequently asked questions

When did Nexalin Technology Inc file this 8-K?
Nexalin Technology Inc (NXL) filed this Current Report (Form 8-K) with the SEC on June 17, 2026. The accession number assigned by EDGAR is 0001829126-26-006624.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Nexalin Technology adopted the Second Amended and Restated Bylaws effective immediately, updating nominations, consent rights, quorum, and forum provisions. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Nexalin Technology Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Nexalin Technology Inc has filed under CIK 1527352, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer